Sign In
Buy AQST
$4.03
+0.100 (+2.54%)
At Close: Jun 03, 2026
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 3)
ABIOMED, Inc. (NASDAQ: ABMD)
ALX Oncology Holdings Inc (NASDAQ: ALXO)
Annexon Inc (NASDAQ: ANNX)
Atossa...
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Aquestive Therapeutics to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference
08:15pm, Tuesday, 28'th Jul 2020
WARREN, N.J., July 28, 2020 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address pati
Aquestive Therapeutics (AQST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
04:33pm, Tuesday, 28'th Jul 2020
Aquestive Therapeutics (AQST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
WARREN, N.J., July 15, 2020 -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that.
Aquestive Therapeutics (AQST) Receives a Buy from Wedbush - Markets
12:16pm, Sunday, 12'th Jul 2020
In a report issued on July 10, Liana Moussatos from Wedbush maintained a Buy rating on Aquestive Therapeutics (AQST –
What Is The Ownership Structure Like For Aquestive Therapeutics, Inc. (NASDAQ:AQST)?
01:49pm, Monday, 06'th Jul 2020
Every investor in Aquestive Therapeutics, Inc. (NASDAQ:AQST) should be aware of the most powerful shareholder groups...
Aquestive Therapeutics (AQST) Receives a Buy from Wedbush - Markets
01:16pm, Tuesday, 30'th Jun 2020
Wedbush analyst Liana Moussatos reiterated a Buy rating on Aquestive Therapeutics (AQST – Research Report) today and set a price
Aquestive Therapeutics (AQST) Receives a Buy from H.C. Wainwright - Markets
10:14am, Tuesday, 30'th Jun 2020
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Aquestive Therapeutics (AQST – Research Report) today and set a
Aquestive Therapeutics, Inc. (AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, ann
Aquestive Therapeutics (AQST) Gets a Buy Rating from Wedbush - Markets
10:50am, Sunday, 28'th Jun 2020
In a report issued on June 26, Liana Moussatos from Wedbush maintained a Buy rating on Aquestive Therapeutics (AQST –
Hedge Funds Aren’t Crazy About Aquestive Therapeutics, Inc. (AQST) Anymore
03:22pm, Thursday, 25'th Jun 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Aquestive Therapeutics (AQST) Investor Presentation - Slideshow
04:06pm, Tuesday, 23'rd Jun 2020
The following slide deck was published by Aquestive Therapeutics, Inc. in conjunction with this event.
Aquestive Therapeutics (AQST) Gets a Buy Rating from Wedbush - Markets
11:28am, Monday, 22'nd Jun 2020
Wedbush analyst Liana Moussatos maintained a Buy rating on Aquestive Therapeutics (AQST – Research Report) on June 19 and set
Aquestive Therapeutics to Present at BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference
12:00pm, Tuesday, 16'th Jun 2020
Aquestive Therapeutics, Inc. (AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, tod
